InsideArbitrage Potential Deal Alert: Keros Therapeutics (KROS) Adopts Poison Pill While Weighing Strategic Alternatives, Including Sale
Keros Therapeutics (KROS) announced that its Board has initiated a formal review process to evaluate strategic alternatives aimed at maximizing stockholder value. To oversee this
Read More